Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22948968

Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2013 Feb
First author
Escherich G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Escherich G
      type
      Author
    2. name
      Zimmermann M
      type
      Author
    3. name
      Janka-Schaub G
      type
      Author
    4. name
      CoALL study group
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Escherich G
      type
      Author
    2. name
      Zimmermann M
      type
      Author
    3. name
      Janka-Schaub G
      type
      Author
    4. name
      CoALL study group
      type
      CollectiveName
    bibliography ids
    1. nci-bib-f9770d40538f56eab203653e
    book metadata
    content sha256
    1b059459d033eb13bb5c8f4539c5c42fc663298d330eb2b8e3ef272133fb69ec
    document type
    citation
    dois
    1. 10.1002/pbc.24273
    electronic publication date
    display
    2012 Sep 4
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22948968
    immutable id
    pubmed:22948968@1b059459d033eb13bb5c8f4539c5c42fc663298d330eb2b8e3ef272133fb69ec
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    2
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    254-7
    volume
    60
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22948968
      provenance
      batch id
      1e3045de9f47a5ccd566
      provider
      NCBI PubMed ESummary
      record sha256
      2f4a2851db52204dab70dd3748bbc1990b947cd769a6ba9e8a514bd991e87f9f
      response sha256
      0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
      retrieved at
      2026-09-09T23:46:50.128287+00:00
      publication date
      display
      2013 Feb
      precision
      month
      year
      2013
      publication types
      1. Comparative Study
      2. Journal Article
      3. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22948968/
      title
      Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03.

      Preserved source evidence · Not medical advice